Search details
1.
Insulin degludec/liraglutide (IDegLira) maintains glycaemic control and improves clinical outcomes, regardless of pre-trial insulin dose, in people with type 2 diabetes that is uncontrolled on basal insulin.
Diabet Med
; 37(2): 267-276, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31705547
2.
Management of people with Type 2 diabetes shared between a specialized outpatient clinic and primary health care is noninferior to management in a specialized outpatient clinic: a randomized, noninferiority trial.
Diabet Med
; 36(7): 854-861, 2019 07.
Article
in English
| MEDLINE | ID: mdl-30614066
3.
Glucose metabolism in patients with psoriasis.
Br J Dermatol
; 180(2): 264-271, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30376181
4.
One-year follow-up on liraglutide treatment for prediabetes and overweight/obesity in clozapine- or olanzapine-treated patients.
Acta Psychiatr Scand
; 139(1): 26-36, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30374965
5.
Use of antibiotics in childhood and risk of Type 1 diabetes: a population-based case-control study.
Diabet Med
; 34(2): 272-277, 2017 02.
Article
in English
| MEDLINE | ID: mdl-27646695
6.
Near-normalization of glycaemic control with glucagon-like peptide-1 receptor agonist treatment combined with exercise in patients with type 2 diabetes.
Diabetes Obes Metab
; 19(2): 172-180, 2017 02.
Article
in English
| MEDLINE | ID: mdl-27717126
7.
Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response.
Nutr Metab Cardiovasc Dis
; 27(12): 1123-1129, 2017 Dec.
Article
in English
| MEDLINE | ID: mdl-29162361
8.
Diabetic and nondiabetic patients with nonalcoholic fatty liver disease have an impaired incretin effect and fasting hyperglucagonaemia.
J Intern Med
; 279(5): 485-93, 2016 May.
Article
in English
| MEDLINE | ID: mdl-26728692
9.
GLP-1 and Amylin in the Treatment of Obesity.
Curr Diab Rep
; 16(1): 1, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26699764
10.
Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: a systematic review and meta-analysis.
Diabetes Obes Metab
; 18(3): 300-5, 2016 Mar.
Article
in English
| MEDLINE | ID: mdl-26537317
11.
Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion.
Diabetes Obes Metab
; 18(6): 571-80, 2016 06.
Article
in English
| MEDLINE | ID: mdl-26888164
12.
Benefits of combination of insulin degludec and liraglutide are independent of baseline glycated haemoglobin level and duration of type 2 diabetes.
Diabetes Obes Metab
; 18(1): 40-8, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26343931
13.
Impaired incretin effect is an early sign of glucose dysmetabolism in nondiabetic patients with psoriasis.
J Intern Med
; 278(6): 660-70, 2015 Dec.
Article
in English
| MEDLINE | ID: mdl-26174490
14.
Transfer of liraglutide from blood to cerebrospinal fluid is minimal in patients with type 2 diabetes.
Int J Obes (Lond)
; 39(11): 1651-4, 2015 Nov.
Article
in English
| MEDLINE | ID: mdl-26228460
15.
Sevelamer in a diabetologist's perspective: a phosphate-binding resin with glucose-lowering potential.
Diabetes Obes Metab
; 17(2): 116-20, 2015 Feb.
Article
in English
| MEDLINE | ID: mdl-25041567
16.
Lack of effect of the glucagon-like peptide-1 receptor agonist liraglutide on psoriasis in glucose-tolerant patients--a randomized placebo-controlled trial.
J Eur Acad Dermatol Venereol
; 29(3): 555-9, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25139195
17.
Decreased plasma chemerin levels in women with gestational diabetes mellitus.
Diabet Med
; 31(8): 936-40, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-24628007
18.
The interleukin-1 receptor antagonist anakinra improves first-phase insulin secretion and insulinogenic index in subjects with impaired glucose tolerance.
Diabetes Obes Metab
; 16(12): 1269-73, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-25039318
19.
Specificity and sensitivity of commercially available assays for glucagon-like peptide-1 (GLP-1): implications for GLP-1 measurements in clinical studies.
Diabetes Obes Metab
; 16(11): 1155-64, 2014 Nov.
Article
in English
| MEDLINE | ID: mdl-25041349
20.
Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies.
Diabetologia
; 56(5): 965-72, 2013 May.
Article
in English
| MEDLINE | ID: mdl-23377698